Danaher Corporation (NASDAQ:DHR) Files An 8-K Results of Operations and Financial Condition

ITEM2.02

On January10, 2017, in advance of a publicly webcast presentation
at the J.P. Morgan Healthcare Conference on January10, 2017,
Danaher Corporation (Danaher or the Company) furnished to
Item2.02 of Form 8-K the presentation slides attached hereto,
which are incorporated by reference herein. The presentation
slides attached hereto contain certain information regarding
Danahers anticipated financial performance for 2016.

Following is required reconciliation and other information
relating to the non-GAAP measures included in the attached
presentation slides:

Free cash flow should be considered in addition to, and not as a
replacement for or superior to, operating cash flow, and may not
be comparable to similarly titled measures reported by other
companies. Management believes that free cash flow provides
useful information to investors by offering additional ways of
viewing Danahers results that, when reconciled to operating cash
flow, helps our investors to understand Danahers ability to
generate cash without external financings, strengthen its balance
sheet, invest in its business and grow its business through
acquisitions and other strategic opportunities (although a
limitation of operating cash flow is that it does not take into
account the Companys debt service requirements and other
non-discretionary expenditures).

This information shall not be deemed filed for purposes of
Section18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.